California's stem cell funding agency giveth and it taketh away: Just last week, the agency awarded more than $250 million to stem cell researchers -- the largest research grant round in its five-year history -- but it also terminated three grants awarded in a previous round due to slow progress earlier this year.
Human embryonic stem cells
Image: Wikimedia commons,
Nissim Benvenisty
The California Institute of Regenerative Medicine (CIRM) identified the underperforming projects by reviewing grantees' first year progress reports. These are required by all CIRM grantees in a progress monitoring system that appears to be more rigorous than that of the National Institutes of Health. "The scientific staff are in frequent contact with our CIRM-supported PIs, assessing their progress towards the goals they were approved to pursue," CIRM director Floyd Bloom linkurl:told the California Stem Cell Report; (CSCR). "Lack of progress can be sufficient grounds to terminate the funding."...
The Scientist

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?